Evaluation of Morbidity and Mortality Data Related to Cardiovascular Calcification from Calcium-Containing Phosphate Binder Use in Patients Undergoing Hemodialysis-Reference-Cited by-同舟云学术

Evaluation of Morbidity and Mortality Data Related to Cardiovascular Calcification from Calcium-Containing Phosphate Binder Use in Patients Undergoing Hemodialysis

Published:2010-07 Issue:7 Volume:30 Page:741-748
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Mason Molly A,Shepler Brian M

Publisher

Wiley

Subject

Pharmacology (medical)

Reference32 articles.

1. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

2. Cardiac calcification in adult hemodialysis patients

3. Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease

4. Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A safety evaluation of sucroferric oxyhydroxide for the treatment of hyperphosphatemia;Expert Opinion on Drug Safety;2021-10-22

2. Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysis;Journal of Medical Economics;2021-01-01

3. How Ultrasound Can Be Useful for Staging Chronic Kidney Disease in Dogs: Ultrasound Findings in 855 Cases;Veterinary Sciences;2020-10-01

4. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts;Aging;2019-06-26

5. Sucroferric oxyhydroxide for the treatment of hyperphosphatemia;Expert Opinion on Pharmacotherapy;2018-07-03